The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, L. M.
Right arrow Articles by Ridley, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, L. M.
Right arrow Articles by Ridley, A. J.
The Journal of Immunology, 2000, 164: 2028-2036.
Copyright © 2000 by The American Association of Immunologists

Lipopolysaccharide Induces Actin Reorganization and Tyrosine Phosphorylation of Pyk2 and Paxillin in Monocytes and Macrophages1

Lynn M. Williams* and Anne J. Ridley2,*,{dagger}

* Ludwig Institute for Cancer Research, Royal Free and University College Medical School, London, United Kingdom; and {dagger} Department of Biochemistry and Molecular Biology, University College London, London, United Kingdom


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The bacterial endotoxin LPS is a potent stimulator of monocyte and macrophage activation and induces adhesion of monocytes. Morphological changes in response to LPS have not been characterized in detail, however, nor have the signaling pathways mediating LPS-induced adhesion been elucidated. We have found that LPS rapidly induced adhesion and spreading of peripheral blood monocytes, and that this was inhibited by the Src family kinase inhibitor PP1 and the phosphatidylinositide 3-kinase inhibitor LY294002. LPS also stimulated actin reorganization, leading to the formation of filopodia, lamellipodia, and membrane ruffles in Bac1 mouse macrophages. Proline-rich tyrosine kinase 2 (Pyk2), a tyrosine kinase related to focal adhesion kinase, and paxillin, a cytoskeletal protein that interacts with Pyk2, were both tyrosine phosphorylated in response to LPS in monocytes and macrophages. Both tyrosine phosphorylation events were inhibited by PP1 and LY294002. Adhesion also stimulated tyrosine phosphorylation of Pyk2 and paxillin in monocytes, and this was further enhanced by LPS. Finally, Pyk2 and paxillin colocalized within membrane ruffles in LPS-stimulated cells. These results indicate that LPS stimulation of monocytes and macrophages results in rapid morphological changes and suggest that Pyk2 and/or paxillin play a role in this response.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Monocyte adhesion to endothelial cells is an essential prerequisite for transmigration leading to their recruitment into tissue and subsequent differentiation into macrophages (1, 2). This adhesion process can be induced by the endotoxin LPS (3). LPS is an outer membrane component of Gram-negative bacteria, and is a potent activator of monocytes and macrophages (4). The subsequent production and release of proinflammatory mediators including IL-1{alpha}, TNF, IL-6, and arachidonic acid metabolites recruit and activate other leukocytes to help fight infection (5). High levels of LPS are a major cause of Gram-negative septic shock, in which LPS induces numerous changes including endothelial injury and activation, leukocyte adhesion to endothelial cells, and generation of free radicals. Lower levels of LPS produced during chronic infections may contribute to the development of other diseases: for example, the pathological changes involved in the initiation and development of atherosclerosis resemble those induced by endotoxin (6), and accumulating data suggest that persistent Gram-negative periodontal disease can lead to the development of cardiovascular disease (7).

The major cell surface receptor for LPS on macrophages is CD14, a 55-kDa glycosylphosphatidylinositol-linked membrane protein (8), although at higher concentrations LPS can bind to other receptors such as the ß2 integrin CD11b/CD18 (9). Recently, the transmembrane protein Toll-like receptor 2 has also been implicated in LPS signaling in macrophages (10). A number of signaling pathways can be activated by LPS, including phospholipases A (11) and C (12), protein kinase C isoforms (13, 14), and the Src family tyrosine kinases Hck, Lyn, and Fgr (15, 16). In monocytes/macrophages, LPS induces the tyrosine phosphorylation of many proteins, including Vav (17) and the mitogen-activated protein kinase (MAPK)3 family members p42/p44 MAPK (18), stress-activated protein kinase 1/c-Jun N-terminal kinase (19), and p38/stress-activated protein kinase 2 (20). LPS also stimulates phosphatidylinositide 3-kinase (PI 3-K) activity in monocytes, resulting in a transient increase in the level of phosphatidylinositol 3,4,5-trisphosphate (21). This process was reported to involve the association of PI 3-K with the Src kinase Lyn and to act upstream of protein kinase C-{zeta} activation (22).

Of the signaling pathways activated by LPS, the p42/p44 MAPK and the p38 pathways have both been shown to be directly involved in the production of the cytokines TNF-{alpha} and IL-1 (20, 23). The functions of other signaling pathways induced by LPS have not been established, and in particular the signaling pathways involved in LPS-induced adhesion have yet to be characterized. In other cell types, focal adhesion kinase (FAK), initially identified as a unique cytoplasmic tyrosine kinase involved in focal adhesions, is thought to play a key role in integrin-mediated cell adhesion (24). Proline-rich tyrosine kinase 2 (Pyk2), also known as related adhesion focal tyrosine kinase or cell adhesion kinase ß (25, 26, 27), is a cytoplasmic tyrosine kinase related to FAK. A Pyk2 splice variant has been identified, termed Pyk2-H or monocyte calcium-dependent tyrosine kinase (28, 29). Pyk2 shows considerable sequence homology and structural similarity to FAK, including consensus motifs in the catalytic domain. Pyk2 expression is more limited than FAK, and has been detected in epithelial cells, neuronal cells, T and B cells, megakaryocytes, platelets, mast cells, and monocytes and macrophages (26, 30, 31), whereas Pyk2-H is only expressed in hemopoietic cells (28, 29). The stimulation of many types of cell surface receptors results in the tyrosine phosphorylation of Pyk2, including integrins, cytokines, and immune receptors (30, 32, 33, 34); and diverse stimuli such as membrane depolarization, stress stimuli, angiotensin, and PMA have all been shown to induce Pyk2 tyrosine phosphorylation, resulting in the activation of its kinase activity (26, 31).

Many proteins localize to focal adhesion sites, in which transmembrane integrins are clustered and link the extracellular matrix with the cytoskeleton (35). Paxillin, a vinculin-binding protein, colocalizes with FAK and integrins in fibroblast focal adhesions (36). Paxillin also binds to Pyk2 (31, 37), and PMA-dependent tyrosine phosphorylation of paxillin in megakaryocytes has been shown to be inhibited using a kinase-dead mutant form of Pyk2, suggesting a functional link between Pyk2 and paxillin (38). As yet, however, there has been no evidence that Pyk2 colocalizes with paxillin.

LPS is known to induce monocyte adhesion (3), but its effects on cytoskeletal organization have not been previously examined in detail. In this study, we have analyzed changes in the actin cytoskeleton induced by LPS in monocytes and macrophages, and correlated them with increased tyrosine phosphorylation of Pyk2 and paxillin.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents

LPS (Salmonella typhi and Escherichia coli serotype 026:B6) was obtained from Sigma-Aldrich (Poole, U.K.). It was reconstituted in pyrogen-free PBS (sonicated for 5 min) and stored at -20°C in glass vials. Immediately before adding to cells, LPS suspensions were sonicated for an additional 2 min before diluting to 10x final concentration in RPMI (Life Technologies, Paisley, U.K.) containing 1% heat-inactivated FCS (HIFCS) (Sigma, Dorset, U.K.) (monocytes and Bac1 cells) or 0.5% HIFCS/RPMI (J774 cells). LPS was protein free, as determined by Bio-Rad protein assay (Bio-Rad, Hercules, CA). PP1 and LY294002 were obtained from Calbiochem (Nottingham, U.K.). The mouse mAb to paxillin was purchased from Transduction Laboratories (Lexington, KY); rabbit polyclonal Pyk2 Abs (600 and 623) were a gift from Dr. I. Dikic (Ludwig Institute for Cancer Research, Uppsala, Sweden); monoclonal phosphotyrosine Py99 was from Santa Cruz Biotechnology (Santa Cruz, CA); and FITC-labeled anti-mouse IgG and tetramethylrhodamine isothiocyanate (TRITC)-labeled anti-rabbit IgG were from Jackson ImmunoResearch (West Grove, PA).

Isolation of peripheral blood monocytes and cell culture

Single donor platelet phoresis residues were purchased from the North London Blood Transfusion Service (Collindale, U.K.). Mononuclear cells were isolated by Ficoll-Hypaque centrifugation (specific density, 1.077 g/ml) preceding monocyte separation in a Beckman JE6 elutriator. Monocyte purity was assessed by flow cytometry using directly conjugated anti-CD45 and anti-CD14 Abs (Leucogate, Becton Dickinson, San Jose, CA) and was routinely greater than 85%. Monocytes were purified in and maintained in RPMI containing 1% HIFCS. All media and sera were routinely tested for endotoxin using the Limulus amoebocyte lysate test (BioWhittaker, Walkersville, MD) and rejected if the endotoxin concentration exceeded 0.1 U/ml.

J774 cells were cultured in RPMI containing 10% HIFCS and supplemented with 25 U/ml of streptomycin and penicillin. They were cultured in RPMI containing 0.5% HIFCS for 48 h before stimulation with LPS. Bac1.2F5 cells were kindly provided by Richard Stanley (Albert Einstein College of Medicine, New York, NY). They were cultured in DMEM supplemented with 10% HIFCS and 20% L cell-conditioned media as a source of CSF-1 (39), and were starved in 1% HIFCS/RPMI (no CSF-1) for 24 h before LPS stimulation.

In some experiments, monocytes or macrophages were pretreated with 10 µM PP1 or 25 µM LY294002 for 15 min before stimulation with LPS. All cultures treated with these inhibitors were assessed for cell viability, as determined by trypan blue (0.04%) (Sigma) exclusion. In all cases, more than 99% of cells were viable.

Immunofluorescence and confocal microscopy

For immunofluorescence studies, cells were fixed with 4% formaldehyde in PBS for 20 min at room temperature. Cells were permeabilized with 0.2% Triton X-100 in PBS for 5 min. For localization of F-actin filaments, cells were incubated with 0.1 µg/ml TRITC-labeled phalloidin (Sigma) for 45 min. For localization of paxillin and Pyk2, cells were blocked with 0.2% heat-inactivated goat serum (Sigma) for 30 min, washed, and then incubated with a 1/12.5 dilution of mouse anti-paxillin Abs and/or a 1/50 dilution of rabbit anti-Pyk2 (600) Abs, washed three times with PBS, and then incubated with a 1/100 dilution of TRITC-conjugated goat anti-mouse IgG and/or FITC-conjugated goat anti-rabbit IgG. Images of cells were obtained using a Zeiss LSM 510 confocal laser-scanning microscope (Welwyn, Garden City, U.K.), using the accompanying LSM 510 software, and were processed in Adobe photoshop 4.0.

Determination of cell spreading

Monocytes (5 x 105/ml) were allowed to adhere to glass coverslips for 30 min before stimulation with LPS (100 ng/ml). Upon termination of the experiment, cells were fixed and stained with TRITC-phalloidin and imaged using confocal microscopy, as described above. Cells with a clearly visible cortical F-actin ring and a diameter equal or less than 10 µm were defined as unspread, whereas cells without a clear cortical ring and a diameter greater than 10 µm were defined as spread.

Western blotting and immunoprecipitations

Following stimulation, cells were lysed for 15 min in lysis buffer (0.5% Nonidet P-40, 30 mM sodium pyrophosphate, 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.1 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF, 10 µg/ml leupeptin, 1 µg/ml pepstatin, and 1 µg/ml aprotinin). Lysates were clarified by centrifugation at 14,000 x g for 10 min. The protein concentration of the cell extracts was determined using the Bio-Rad protein assay kit (Bio-Rad, Hercules, CA). The clarified lysates were precleared with either anti-mouse IgG (for subsequent paxillin immunoprecipitations) or rabbit serum (for Pyk2 immunoprecipitations) with protein A-Sepharose (Pharmacia, Uppsala, Sweden). Immunoprecipitations were performed using either anti-paxillin or anti-Pyk2 Abs and protein A-Sepharose. The immunoprecipitates were then washed in lysis buffer before addition of 2x gel sample buffer, heated to 95°C for 3 min, and subsequently analyzed by SDS-PAGE, followed by electrophoretic transfer to polyvinylidene difluoride membranes (Immobilon-P; Millipore, Bedford, MA).

Membranes were blocked in 5% BSA and probed with a 1/4000 dilution of the anti-phosphotyrosine Ab PY99. Blots were visualized with HRP-conjugated donkey anti-rabbit Ab (1/8000) (Amersham, Little Chalfont, U.K.) and developed using enhanced chemiluminescence (ECL; Amersham). Membranes were either stripped in 0.1 mM glycine, pH 2, and reprobed with anti-paxillin Abs (Transduction Laboratories), or alternatively stripped with 2% SDS, 25 mM Tris, pH 6.8, and 100 mM 2-ME, and subsequently reprobed with anti-Pyk2 (600) Abs.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
LPS induces morphological changes and actin reorganization in human monocytes and murine Bac1 macrophages

LPS induced distinct changes in cell morphology and actin organization in monocytes (Fig. 1Go, a–f) and Bac1 mouse macrophage cells (Fig. 1Go, g–j). When unstimulated monocytes were allowed to adhere to glass coverslips for 90 min, the majority did not spread significantly (Table IGo) and maintained a cortical ring of actin filaments (Fig. 1Go, a). This adhesion was transient, and more than 90% of cells detached again by 24 h. In the presence of LPS, however, monocytes displayed a considerably greater degree of spreading (Fig. 1Go, b–f; Table IGo), and this adhesion was stable and maintained for over 24 h. LPS-induced spreading was morphologically indistinguishable whether it was added to monocytes before or after they were allowed to adhere to coverslips (data not shown). In addition to this increase in cell spreading, LPS induced cell polarization indicative of cell migration (40), as defined by the asymmetric morphology of LPS-treated cells. Typically, one region of the cell periphery displayed membrane ruffles (indicated by the arrowheads in Fig. 1Go, d and f) and lamellipodia, characteristic of the leading edge of a motile cell, whereas the opposite edge was rounded or displayed retraction fibers (arrowhead in Fig. 1Goe), typical of the trailing edge of a motile cell. Time-lapse videomicroscopy confirmed that actively migrating cells were present in LPS-stimulated monocyte cultures (data not shown).



View larger version (55K):
[in this window]
[in a new window]
 
FIGURE 1. LPS-induced morphological changes and actin reorganization in human monocytes and Bac1 macrophages. Actin cytoskeletal organization is shown in human monocytes (a–f) and Bac1 macrophages (g–j). Human monocytes (5 x 105/ml) were seeded onto glass coverslips and allowed to adhere for 30 min. Cells were then left unstimulated (a), or stimulated with either 100 ng/ml LPS (b–d) or 100 ng/ml heat-inactivated LPS (e and f) for 60 min. The images in c and d are sections of the same cell, showing a basal (c) and more apical (d) section. Similarly, e and f show basal and apical sections of the same cell. Bac1 macrophages (5 x 104/ml) were allowed to adhere to coverslips overnight before the removal of CSF-1. Twenty-four hours after CSF-1 removal, the cells were left unstimulated (g) or stimulated with LPS (1 µg/ml) for 20 min (h and i) or 60 min (j). Cells were fixed and stained with TRITC-labeled phalloidin to reveal actin filaments. Arrowheads indicate membrane ruffles (d, f); retraction fibers (e); a filopodium (h); lamellipodia (i and j). Bar in a represents 10 µm and refers to a–f; bar in g represents 10 µm and refers to g–j.

 

View this table:
[in this window]
[in a new window]
 
Table I. LPS enhances adhesion and spreading of monocytes1

 
To control for the presence of contaminating bacterial toxins in the LPS, a sample was heat inactivated for 60 min. There were no detectable differences in the morphological responses observed between non-heat-inactivated (Fig. 1Go, a–d) and heat-inactivated (Fig. 1Go, e and f) LPS, indicating that the responses observed were due to LPS itself rather than to any heat-sensitive contaminant.

When Bac1 macrophages are deprived of CSF-1, they take on a rounded morphology (Fig. 1Gog) (41). Upon LPS stimulation, the cells responded rapidly by extending filopodia (e.g., arrowhead in Fig. 1Goh) and lamellipodia (e.g., arrowhead in Fig. 1Goi). Membrane ruffles were also observed on the dorsal surface of cells (Fig. 7Go, i and j). By 60 min (Fig. 1Goj), the cells were more polarized and some cells displayed punctate F-actin staining (arrowhead) similar to that observed in monocytes (e.g., Fig. 1Goe), localized toward the presumptive leading edge of the cells. Bac1 cells were less sensitive to LPS than monocytes, and morphological changes were most clearly observed at 1 µg/ml LPS, whereas human monocytes responded morphologically to LPS at both 100 ng/ml (Fig. 1Go) and 10 ng/ml, but showed little response at 1 ng/ml (data not shown). This difference between Bac1 cells and monocytes could reflect receptor levels and/or different types of receptors.



View larger version (81K):
[in this window]
[in a new window]
 
FIGURE 7. Localization of paxillin and Pyk2 in monocytes. Human monocytes (a–h) were seeded at 5 x 105/ml in 1% HIFCS onto glass coverslips. Monocytes were allowed to adhere to coverslips for 30 min, and then were left unstimulated (a and b) or stimulated with LPS (100 ng/ml) for 60 min (c–h). Cells were fixed and dual stained to show paxillin (a and g) and Pyk2 (b and h) localization, or dual stained to show actin filaments (c and e) and Pyk2 localization (d and f). The images in c and d show a basal section, and in e and f a more apical section of the same cells. Arrows in c and d indicate colocalization of Pyk2 and actin filaments; arrowheads in e and f indicate an example of colocalization of actin filaments and Pyk2 in membrane ruffles; arrows in g and h show colocalization of paxillin and Pyk2 at the plasma membrane; while arrowheads in g indicate paxillin-containing focal complexes, in which Pyk2 does not colocalize. Bar: 10 µm (a and b, c–f, g and h are at the same magnification).

 
LPS induces tyrosine phosphorylation of Pyk2 and paxillin in human monocytes and the murine macrophage cell line J774

To investigate the signaling processes involved in LPS-induced adhesion and spreading, we initially examined the ability of LPS to activate Pyk2. Pyk2 was chosen as although it was previously reported that FAK is expressed in human peripheral monocytes (42), in agreement with other workers (28), we were unable to detect any FAK expression in either human monocytes or murine macrophage cell lines. We therefore concentrated our studies to Pyk2, which is abundantly expressed in cells of the monocyte/macrophage lineage.

Freshly isolated human peripheral blood monocytes were stimulated in suspension with 100 ng/ml LPS for different lengths of time, and then analyzed for Pyk2 tyrosine phosphorylation (Fig. 2Go). The Ab used to immunoprecipitate Pyk2 (600) detects both of the Pyk2 isoforms expressed in monocytes (29). An increase in Pyk2 tyrosine phosphorylation was consistently induced by LPS in monocytes, and maximum Pyk2 phosphorylation was observed between 15–30 min after LPS addition. The experiments were performed in the presence of 1% HIFCS, to facilitate LPS binding to CD14 via LPS-binding protein present in serum (8). In the presence of 10% HIFCS, Pyk2 tyrosine phosphorylation was induced in the absence of LPS (data not shown). This could be a consequence of lysophosphatidic acid present in serum, since lysophosphatidic acid has been shown to stimulate Pyk2 phosphorylation in PC12 cells (43).



View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 2. Kinetics of LPS-induced tyrosine phosphorylation of Pyk2 and paxillin in human monocytes. Human monocytes were kept in suspension and were stimulated with 100 ng/ml of LPS for the times indicated. Cell lysates were immunoprecipitated with either anti-Pyk2 (600) or anti-paxillin Abs and analyzed by immunoblotting with the anti-phosphotyrosine Ab PY99. Membranes were stripped and reprobed with anti-Pyk2 (623) or anti-paxillin Abs. The data are representative of three experiments performed using different donors.

 
As Pyk2 has been shown to bind to paxillin both in vitro and in vivo, we investigated whether LPS also altered paxillin phosphorylation. LPS stimulated tyrosine phosphorylation of paxillin with similar kinetics to those observed with Pyk2 phosphorylation (Fig. 2Go). Reprobing with anti-paxillin Abs demonstrated that there was an increase in lower mobility forms of paxillin, suggesting that paxillin is also serine phosphorylated at multiple sites in response to LPS stimulation, as has been observed following adhesion of macrophages to vitronectin (44).

Although CD14 is believed to be the principal receptor for LPS on macrophages, at higher concentrations LPS has been shown to bind to other cell surface proteins, including the ß2 integrin complement receptor type 3 (9). As engagement of integrins has been shown to result in both Pyk2 and paxillin tyrosine phosphorylation (30, 44), it was important to determine the sensitivity of this response to LPS concentrations. LPS was capable of stimulating the tyrosine phosphorylation of both Pyk2 and paxillin at concentrations below 100 ng/ml (Fig. 3Go), indicating that this response is via binding to the high affinity receptor CD14.



View larger version (71K):
[in this window]
[in a new window]
 
FIGURE 3. Dose response for LPS-induced tyrosine phosphorylation of Pyk2 and paxillin in human monocytes. Human monocytes were kept in suspension or allowed to adhere to tissue culture plastic (for 30 min) before stimulation with LPS (0–100 ng/ml for 30 min). Cell lysates were immunoprecipitated with either anti-Pyk2 (600) or anti-paxillin Abs and analyzed via immunoblotting with the anti-phosphotyrosine Ab PY99. Membranes were stripped and reprobed with anti-Pyk2 (623) or anti-paxillin Abs. The data are representative of three experiments performed using different donors.

 
Pyk2 has been reported to become tyrosine phosphorylated upon monocyte adhesion to tissue culture plastic (28). We similarly observed tyrosine phosphorylation of Pyk2 and also paxillin in response to adhesion (Fig. 3Go). However, once the monocytes had been allowed to adhere to tissue culture plastic (in 1% HIFCS), LPS stimulated a further increase in the level of tyrosine phosphorylation of Pyk2 and paxillin (Fig. 3Go).

To determine whether LPS could also induce paxillin and Pyk2 phosphorylation in macrophages, we investigated LPS responses in two adherent murine macrophage cell lines. In J774 cells, some constitutive Pyk2 tyrosine phosphorylation was observed, even at low serum concentrations (0.5%) (Fig. 4Goa). However, as in adherent monocytes, LPS enhanced the levels of tyrosine phosphorylation of both Pyk2 and paxillin: increased tyrosine phosphorylation was detected within 5 min and remained elevated for up to 2 h. In Bac1 cells, both Pyk2 and paxillin were constitutively tyrosine phosphorylated, and the level of Pyk2 tyrosine phosphorylation was not significantly increased when stimulated with LPS, even at high concentrations of 1 µg/ml (Fig. 4Gob, left panels). In contrast, LPS stimulated an increase in paxillin phosphorylation (Fig. 4Gob, right panels). When Bac1 cells were gently detached from the tissue culture plates, and kept in suspension for 3 h before stimulation, the level of Pyk2 phosphorylation was unaltered, but paxillin tyrosine phosphorylation was significantly decreased (Fig. 4Gob). LPS was incapable of stimulating increased phosphorylation of either Pyk2 or paxillin in these suspended cells. This suggests that Bac1 cells differ from monocytes and J774 cells in that Pyk2 tyrosine phosphorylation is already high as a consequence of other, unknown, signals, and cannot be further enhanced by either LPS or adhesion. In contrast, paxillin phosphorylation is regulated by LPS, but only in adherent Bac1 cells.



View larger version (48K):
[in this window]
[in a new window]
 
FIGURE 4. Analysis of Pyk2 and paxillin tyrosine phosphorylation in response to LPS in murine macrophages. Adherent cultures of J774 cells (a) were cultured in 0.5% HIFCS for 48 h before stimulation with LPS (1 µg/ml) for the times indicated. Bac1 cells (b) were incubated in medium containing 1% HIFCS (no CSF-1) for 24 h, and then were either left attached or detached and kept in suspension for 3 h before stimulation with LPS (1 µg/ml for 30 min). Cell lysates were immunoprecipitated with either anti-Pyk2 (600) or anti-paxillin Abs and analyzed by immunoblotting with the anti-phosphotyrosine Ab PY99. Membranes were stripped and reprobed with anti-Pyk2 (623) or anti-paxillin Abs.

 
The Src kinase inhibitor PP1 and the PI 3-K inhibitor LY294002 inhibit LPS-induced Pyk2 and paxillin tyrosine phosphorylation and LPS-induced cell spreading in human monocytes

To investigate the signaling pathways leading to Pyk2 and paxillin phosphorylation, we have focused on two potential upstream signal transducers. LPS has been shown to activate PI 3-K (21) and the Src family members Hck, Lyn, and Fgr (15, 16) within minutes of stimulation. In addition, PI 3-K physically associates with Lyn, suggesting that they may act coordinately to regulate downstream signaling (21). Using the Src family kinase inhibitor PP1 (45) or the PI 3-K inhibitor LY294002 (46), we determined the roles of the targets of these compounds in LPS responses. Preincubation of monocytes with either PP1 or LY294002 strongly inhibited the LPS-induced phosphorylation of paxillin and Pyk2 (Fig. 5Go). PP1 reduced both paxillin and Pyk2 tyrosine phosphorylation below levels detected in unstimulated cells, suggesting that basal as well as stimulated levels of tyrosine phosphorylation are regulated by Src family kinases. LY294002 reduced the level of phosphorylation to that observed in unstimulated cells. Consistent with previous reports (31, 47, 48), we observed coimmunoprecipitation of Pyk2 with paxillin (Fig. 5Goa, left panel). Interestingly, LPS stimulation did not increase the amount of Pyk2 coimmunoprecipitating with paxillin, despite inducing tyrosine phosphorylation of Pyk2. In addition, PP1 and LY294002 did not alter the association of Pyk2 with paxillin, indicating that this interaction is not regulated by tyrosine phosphorylation of Pyk2 or paxillin, in agreement with other workers (31, 47, 48).



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 5. The Src family kinase inhibitor PP1 and the PI 3-K inhibitor LY294002 inhibit LPS-induced Pyk2 and paxillin tyrosine phosphorylation in human monocytes. Human monocytes were kept in suspension, and preincubated with either PP1 (10 µM), LY294002 (25 µM), or DMSO control (0.1%) for 15 min before stimulation with 100 ng/ml of LPS for 30 min. Cell were lysed and immunoprecipitated with either a, anti-paxillin or b, anti-Pyk2 (600), and immunoprecipitates analyzed by immunoblotting with the anti-phosphotyrosine Ab PY99. Membranes were stripped and reprobed with anti-Pyk2 (623) or anti-paxillin Abs. The data are representative of three experiments performed using different donors.

 
To determine whether Src family kinases and PI 3-K could be involved in LPS-induced morphological changes, PP1 and LY294002 were incubated with monocytes before LPS addition. Both PP1 and LY294002 prevented LPS-induced monocyte spreading (Fig. 6Go, a–d and f). Even cells that did spread (diameter >10 µm) to a limited degree remained unpolarized. In addition, by 60 min after LPS stimulation, PP1 and LY294002 induced a significant reduction in the number of adherent monocytes (Fig. 6Go, a–d and e). Both inhibitors also prevented the transient adhesion of monocytes to glass coverslips in the absence of LPS (data not shown), consistent with a role for Src kinases and PI 3-K in adhesion-induced signaling. The effects of PP1 and LY294002 on monocyte morphology were reversible, as if the inhibitors were removed from the cultures by washing; the cells were able to adhere and respond normally to LPS, indicating that the inhibitors were not exerting some nonspecific toxic effect upon the monocytes.



View larger version (64K):
[in this window]
[in a new window]
 
FIGURE 6. PP1 and LY294002 inhibit LPS-induced cell spreading. Human monocytes (5 x 105/ml) were seeded in 1% HIFCS onto glass coverslips. Cells were allowed to adhere to coverslips for 30 min before incubation with either DMSO control (0.1%) (a and b), LY294002 (25 µM) (c), or PP1 (5 µM) (d) for 15 min before stimulation with LPS (100 ng/ml) (b, c and d) for 60 min (unstimulated in a). Cells were fixed and stained with TRITC-labeled phalloidin to reveal actin filaments. Bar: 10 µm (a–d are at the same magnification). A quantitative analysis of cell adhesion and spreading efficiency was obtained by calculating the percentage of spread cells (e and f). Data represent the mean of three independent experiments (using three separate donors), in which each individual experiment represents the mean of four randomly chosen frames. p values were determined using Student’s t test: *, p < 0.05; **, p < 0.01; ***, p < = 0.005. Both inhibitors significantly decreased spreading (p values of PP1 (p = 0.006) and LY294002 (p = 0.002) compared with LPS alone) and the number of adherent cells (p values of PP1 (p = 0.017) and LY294002 (p = 0.012) compared with LPS alone).

 
Localization of paxillin and Pyk2 in monocytes and Bac1 macrophages

Our observation that PP1 and LY294002 inhibited both LPS-induced morphological changes and phosphorylation of Pyk2 and paxillin suggested that Pyk2 and/or paxillin could be involved in the morphological responses to LPS. We therefore investigated the localization of Pyk2 and paxillin with respect to the actin cytoskeleton. In unstimulated monocytes, both paxillin and Pyk2 were distributed diffusely throughout the cytoplasm (Fig. 7Go, a and b). Upon LPS stimulation and subsequent cell spreading, Pyk2 was found to concentrate, with F-actin, at the leading edge of polarized cells (as shown in the basal plane, Fig. 7Go, c and d). Pyk2 did not localize to podosomes, identified as punctate foci of F-actin (Fig. 7Goc; podosomes indicated by arrows), which are adhesion sites found in cells of monocytic origin (49, 50). Pyk2 also did not localize to podosomes in human macrophages differentiated from monocytes (data not shown). In contrast, vinculin localized to podosomes, as previously described (50), as did paxillin (data not shown).

In medial sections of cells, Pyk2 localized within F-actin-rich membrane ruffles (Fig. 7Go, e and f; arrowhead indicates a membrane ruffle). Paxillin (Fig. 7Gog) and Pyk2 (Fig. 7Goh) colocalized in the perinuclear area of cells and at the plasma membrane (e.g., arrows in Fig. 7Go, g and h), consistent with their coimmunoprecipitation from cell lysates (Fig. 5Goa). Paxillin also localized to small focal complexes observed in some areas at the periphery of LPS-stimulated monocytes (Fig. 7Gog; basal section, arrowheads indicate examples of focal complexes). Pyk2 did not detectably colocalize with paxillin in these focal complexes (Fig. 7Goh), indicating that Pyk2 and paxillin are not always associated. Similarly, paxillin and Pyk2 colocalized in protrusions of Bac1 cells (Fig. 8Go, a and b), but Pyk2 clearly did not localize to paxillin-containing focal complexes. As in monocytes, paxillin and Pyk2 colocalized in membrane ruffles of Bac1 cells (Fig. 8Go, c and d).



View larger version (105K):
[in this window]
[in a new window]
 
FIGURE 8. Localization of paxillin and Pyk2 in Bac1 macrophages. Growing Bac1 cells were fixed and dual stained to show paxillin (a and c) and Pyk2 (b and d). A basal section shows that paxillin, but not Pyk2, localizes to focal complexes (a and b), whereas both paxillin and Pyk2 colocalize in membrane ruffles in a medial section (c and d) through the same cell. Bar: 10 µm.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The effects of LPS on cytokine production in monocytes and macrophages have been extensively studied, whereas its effects on cell morphology have not been characterized in detail. We have shown that LPS rapidly stimulates actin reorganization in monocytes and macrophages, and promotes monocyte adhesion and spreading. These responses to LPS are likely to be important in stimulating monocyte adhesion to and transmigration across endothelial cells, as well as recruitment of macrophages to sites of infection. Identifying signaling pathways mediating LPS-induced morphological responses is therefore central to our understanding of how LPS acts in vivo. We have observed that two proteins extensively implicated in adhesion-induced signaling, Pyk2 and paxillin, are tyrosine phosphorylated in response to LPS and are found within membrane ruffles and lamellipodia in LPS-stimulated monocytes. The Src kinase family inhibitor PP1 and the PI 3-K inhibitor LY294002 prevent LPS-induced monocyte spreading and concomitantly inhibit tyrosine phosphorylation of Pyk2 and paxillin, suggesting that Pyk2 and/or paxillin play a role in LPS-induced morphological changes.

In monocytes, Pyk2 has been shown to be tyrosine phosphorylated upon adhesion (28), and we have similarly observed that adhesion stimulates Pyk2 and paxillin tyrosine phosphorylation. When monocytes are kept in suspension, Pyk2 is not responsive to stimuli such as PMA, RANTES, and thapsigargin, although these stimuli enhance tyrosine phosphorylation of Pyk2 in adherent monocytes (28). In contrast, we have found that LPS is able to induce Pyk2 and paxillin tyrosine phosphorylation in suspension as well as in adherent monocytes. This indicates that neither Pyk2 nor paxillin requires signals provided by adhesion to become tyrosine phosphorylated, but that adhesion enhances the response to LPS. Interestingly, LPS induces morphological changes in adherent Bac1 macrophages without detectably altering Pyk2 tyrosine phosphorylation. In contrast, LPS does increase paxillin phosphorylation, and therefore it is plausible that in these cells paxillin but not Pyk2 contributes to LPS-induced morphological changes. It is also possible that Pyk2 is involved, but only in concert with paxillin and other proteins. Indeed, our observation that Pyk2 localizes to membrane ruffles and lamellipodia suggests that its site of action is in these structures, where new adhesions are formed during cell spreading and migration (40). As Pyk2 tyrosine phosphorylation remains elevated in Bac1 cells even in suspension, it is possible that these cells constitutively secrete one or more chemokine that acts in an autocrine fashion to activate Pyk2, as several chemokines have been shown to activate Pyk2 (28, 29).

We have shown that the Src family-specific inhibitor PP1 prevented LPS-induced tyrosine phosphorylation of Pyk2 and paxillin. Potential Src family members involved in this response are Hck, Lyn, and Fgr, which are all activated within minutes of LPS stimulation (15, 16). Pyk2 has been shown to associate directly with the Src kinases Fyn, Lck, and Src, and Fyn can phosphorylate Pyk2 in vitro (33, 43, 51, 52). In T cells, Pyk2 tyrosine phosphorylation is regulated by Lck or Fyn, depending on the stimulus (51, 52). Activated Pyk2 in turn may phosphorylate paxillin, as it interacts directly via its C terminus with paxillin and can phosphorylate it in vitro (37, 53). However, although a proportion of Pyk2 is constitutively associated and colocalizes with paxillin in cells, their tyrosine phosphorylation does not always correlate. For example, ligation of CD28 in Jurkat T cells stimulates Pyk2, but not paxillin tyrosine phosphorylation (54). In addition, CD3- and CD45-induced phosphorylation of paxillin, but not Pyk2, is dependent on the Src family kinase Lck in T cells (47). It is therefore likely that Pyk2 and paxillin tyrosine phosphorylation can be regulated independently of each other. Indeed, it appears that Src kinases rather than FAK are responsible for paxillin tyrosine phosphorylation during spreading of chicken embryo cells (55). Pyk2 may therefore act as an adaptor to bring paxillin and Src kinases together, as has been proposed for FAK (55). In the context of LPS signaling, it would therefore be of interest to determine whether Pyk2 or paxillin are direct substrates of Hck, Lyn, or Fgr.

Pyk2 can be activated by a diverse spectrum of stimuli, but there is substantial variation in the kinetics of its tyrosine phosphorylation. Chemokine and integrin receptor engagement leads to the phosphorylation of Pyk2 within minutes (29, 48, 56), whereas other stimuli such as IL-2 and fluoroaluminate require a longer time period (greater than 10 min) to induce the maximum level of Pyk2 phosphorylation (57, 58). The kinetics of LPS-induced Pyk2 and paxillin tyrosine phosphorylation in monocytes fall into the latter category, as maximum phosphorylation was not observed until after 15 min. This delay could be a consequence of a rate-limiting step involving auto/transphosphorylation of Pyk2, before Src kinases can bind and further stimulate tyrosine phosphorylation.

We have found that the PI 3-K inhibitor LY294002 prevents LPS-induced tyrosine phosphorylation of Pyk2 and paxillin. PI 3-K itself is activated by both receptor and nonreceptor tyrosine kinases (59). LPS-induced PI 3-K activation in monocytes is inhibited by the tyrosine kinase inhibitor herbimycin A, and Lyn associates with PI 3-K (21), suggesting that it or a related kinase mediates PI 3-K activation by LPS. The PP1 inhibitor may therefore target both a Src kinase involved in LPS-induced activation of PI 3-K and also a Src kinase(s) involved in phosphorylating Pyk2 and paxillin. Precisely how PI 3-K contributes to Pyk2 or paxillin tyrosine phosphorylation is unclear, but it is possible that it involves a member of the Tec family of Src-related tyrosine kinases, which bind to and are activated by the PI 3-K lipid product phosphatidylinositol 3,4,5-trisphosphate via their pleckstrin homology domains (59, 60). Pyk2 can interact with PI 3-K (61), and this could facilitate Pyk2 and paxillin localization to sites of PI 3-K activity, where a Tec family kinase could then tyrosine phosphorylate them. PI 3-K may also contribute to cell spreading by acting upstream of the GTPase Rac (62), which regulates the formation of lamellipodia and membrane ruffles in many cell types, including Bac1 macrophages (63, 64). Interestingly, paxillin has recently been shown to interact with two components of the Rac signaling pathway, PAK (p21-activated kinase) and PIX (PAK-interacting guanine nucleotide exchange factor) (65), and thus it is possible that Pyk2 and paxillin are part of a large complex of proteins involved in regulating lamellipodium extension and the formation of new adhesion sites.

The subcellular localization of Pyk2 has not previously been described in monocytes and macrophages. Studies in smooth muscle cells (66), fibroblasts (67), and FAK-/- fibroblasts (68) have revealed a predominantly perinuclear localization of Pyk2. Similarly, we have observed that Pyk2 and paxillin have a perinuclear distribution in monocytes and macrophages. In addition, in LPS-stimulated cells, Pyk2 was observed at the plasma membrane, colocalizing with F-actin and paxillin in lamellipodia and membrane ruffles. Ectopic expression of hemagglutinin-tagged Pyk2 in J774 cells confirmed that Pyk2 was present in membrane ruffles (our unpublished data). As lamellipodia extend over the substratum, new integrin-mediated adhesions known as focal complexes form (40), and many cytoplasmic proteins including FAK, vinculin, and paxillin localize to these complexes (63, 64). Dual staining for Pyk2 and paxillin demonstrated that although Pyk2 and paxillin colocalized in membrane ruffles, Pyk2 was not found within paxillin-containing focal complexes. Pyk2 also did not localize to podosomes, which are punctate sites of adhesion commonly observed in cells of monocytic origin (49, 50). This suggests that Pyk2-paxillin interaction occurs in membrane ruffles and/or in the perinuclear region rather than in focal complexes or podosomes. In fibroblasts, a small proportion of Pyk2 was shown to localize in the vicinity of focal adhesions (67, 68), although it had a patchy distribution unlike that of vinculin or paxillin. In contrast, Pyk2 has been reported to colocalize with vinculin in focal adhesions in neutrophils (69). It will therefore be important to determine the precise role that paxillin, and other paxillin family members such as Hic-5 and leupaxin (67, 70), plays in the localization and function of Pyk2 and associated proteins in different cell types.

In conclusion, our observations that LPS-induced monocyte adhesion and spreading are accompanied by Pyk2 and paxillin tyrosine phosphorylation, and that PP1 and LY294002 inhibit both of these responses, suggest that Pyk2 and/or paxillin play an important role in LPS-mediated morphological changes. In addition, the localization of Pyk2 and paxillin in membrane ruffles and lamellipodia is consistent with a role for these proteins in cell motility. Paxillin in particular has been implicated as playing an important role in cell spreading (55). Future studies with mutants of Pyk2 and paxillin should delineate more precisely how each protein contributes to LPS-induced monocyte and macrophage motility responses. As a variety of stimuli can induce Pyk2 and paxillin tyrosine phosphorylation in monocytes, it is likely that in vivo different signals, including LPS, cytokines, and extracellular matrix proteins, act coordinately to stimulate signaling pathways promoting monocyte motility.


    Acknowledgments
 
We are grateful to the staff at the Kennedy Institute of Rheumatology (London, U.K.), in particular Brien Foxwell and T. Green, for the use of their elutriator in the preparation of monocytes; to Richard Stanley (Albert Einstein College of Medicine, New York, NY) for providing Bac1.2F5 cells; and to Gareth Jones (King’s College, London, U.K.) for advice on their nurture and discussion of results. We thank Ivan Dikic (Ludwig Institute for Cancer Research) for the anti-Pyk2 Abs and the hemagglutinin-tagged Pyk2 vectors.


    Footnotes
 
1 This work was supported by a Human Frontiers Scientific Program Grant RG304/96. Back

2 Address correspondence and reprint requests to Dr. Anne J. Ridley, Ludwig Institute for Cancer Research, 91 Riding House Street, London W1P 8BT, U.K. E-mail address: Back

3 Abbreviations used in this paper: MAPK, mitogen-activated protein kinase; FAK, focal adhesion kinase; HIFCS, heat-inactivated FCS; PI 3-K, phosphatidylinositide 3-kinase; PP1, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; Pyk2, proline-rich tyrosine kinase 2; TRITC, tetramethylrhodamine isothiocyanate. Back

Received for publication September 15, 1999. Accepted for publication December 8, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Beekhuizen, H., R. van der Furth. 1993. Monocyte adherence to human vascular endothelium. J. Leukocyte Biol. 54:363.[Abstract]
  2. Juliano, R. L., S. Haskill. 1993. Signal transduction from the extracellular matrix. J. Cell Biol. 120:577.[Free Full Text]
  3. Doherty, D. E., L. Zagarella, P. M. Henson, G. S. Worthen. 1989. Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell. J. Immunol. 143:3673.[Abstract]
  4. Morrison, D. C., J. L. Ryan. 1979. Bacterial endotoxins and the host immune responses. Adv. Immunol. 28:293.[Medline]
  5. Morrison, D. C.. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417.[Medline]
  6. Liao, W.. 1996. Endotoxin: possible roles in the initiation and development of atherosclerosis. J. Lab. Clin. Med. 128:452.[Medline]
  7. Beck, J. D., S. Offenbacher, R. Williams, P. Gibbs, R. Garcia. 1998. Periodontitis: a risk factor for coronary heart disease?. Ann. Periodontol. 3:127.[Medline]
  8. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.[Abstract/Free Full Text]
  9. Wright, S. D., M. T. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876.[Abstract/Free Full Text]
  10. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediates lipoloysaccharide-induced cellular signalling. Nature 395:284.[Medline]
  11. Forehand, J. R., Jr R. Johnston, J. S. Bomalaski. 1993. Phospholipase A2 activity in human neutrophils: stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. J. Immunol. 151:4918.[Abstract]
  12. Buscher, D., R. A. Hipskind, S. Krautwald, T. Reimann, M. Baccarini. 1995. Ras-dependent and -independent pathways target the mitogen-activated protein kinase network in macrophages. Mol. Cell. Biol. 15:466.[Abstract]
  13. Shapira, L., S. Takashiba, C. Champagne, S. Amar, T. E. Van-Dyke. 1994. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-{alpha} and IL-1ß production by human monocytes. J. Immunol. 153:1818.[Abstract]
  14. Geng, Y., B. Zhang, M. Lotz. 1993. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151:6692.[Abstract]
  15. Stefanova, I., M. L. Corcoran, E. M. Horak, L. M. Wahl, J. B. Bolen, I. D. Horak. 1993. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J. Biol. Chem. 268:20725.[Abstract/Free Full Text]
  16. Beaty, C. D., T. L. Franklin, Y. Uehara, C. B. Wilson. 1994. Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24:1278.[Medline]
  17. Geng, Y., E. Gulbins, A. Altman, M. Lotz. 1994. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA 91:8602.[Abstract/Free Full Text]
  18. Liu, M. K., V. P. Herrera, R. W. Brownsey, N. E. Reiner. 1994. CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153:2642.[Abstract]
  19. Hambleton, J., S. L. Weinstein, L. Lem, A. L. DeFranco. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA 93:2774.[Abstract/Free Full Text]
  20. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.[Medline]
  21. Herrera-Velit, P., N. E. Reiner. 1996. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes. J. Immunol. 156:1157.[Abstract]
  22. Herrera, V. P., K. L. Knutson, N. E. Reiner. 1997. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-{zeta} in bacterial lipopolysaccharide-treated human monocytes. J. Biol. Chem. 272:16445.[Abstract/Free Full Text]
  23. Foey, A., S. L. Parry, L. M. Williams, F. M. Brennan, B. M. J. Foxwell. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF{alpha}: role of p38 and p42/p44 MAP kinases. J. Immunol. 160:926.
  24. Zachary, I., E. Rozengurt. 1992. Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71:891.[Medline]
  25. Avraham, S., R. London, Y. Fu, S. Ota, D. Hiregowdara, J. Li, S. Jiang, L. M. Pasztor, R. A. White, J. E. Groopman, H. Avraham. 1995. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J. Biol. Chem. 270:27742.[Abstract/Free Full Text]
  26. Lev, S., H. Moreno, R. Martinez, P. Canoll, E. Peles, J. M. Musacchio, G. D. Plowman, B. Rudy, J. Schlessinger. 1995. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions. Nature 376:737.[Medline]
  27. Sasaki, H., K. Nagura, M. Ishino, H. Tobioka, K. Kotani, T. Sasaki. 1995. Cloning and characterization of cell adhesion kinase ß, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J. Biol. Chem. 270:21206.[Abstract/Free Full Text]
  28. Li, X., D. Hunter, J. Morris, J. S. Haskill, H. S. Earp. 1998. A calcium-dependent tyrosine kinase splice variant in human monocytes. J. Biol. Chem. 273:9361.[Abstract/Free Full Text]
  29. Dikic, I., I. Dikic, J. Schlessinger. 1998. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signalling. J. Biol. Chem. 273:14301.[Abstract/Free Full Text]
  30. Li, J., H. Avraham, R. A. Rogers, S. Raja, S. Avraham. 1996. Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes. Blood 88:417.[Abstract/Free Full Text]
  31. Li, X., H. S. Earp. 1997. Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J. Biol. Chem. 272:14341.[Abstract/Free Full Text]
  32. Astier, A., S. N. Manie, H. Avraham, H. Hirai, S. F. Law, Y. Zhang, E. A. Golemis, Y. Fu, B. J. Druker, N. Haghayeghi, A. S. Freedman, S. Avraham. 1997. The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas-like protein, p105HEF1. J. Biol. Chem. 272:19719.[Abstract/Free Full Text]
  33. Ganju, R. K., W. C. Hatch, H. Avraham, M. A. Ona, B. Druker, S. Avraham, J. E. Groopman. 1997. RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes. J. Exp. Med. 185:1055.[Abstract/Free Full Text]
  34. Okazaki, H., J. Zhang, M. M. Hamawy, R. P. Siraganian. 1998. Activation of protein-tyrosine kinase PYK-2 is downstream of Syk in FC{epsilon}RI signaling. J. Biol. Chem. 272:32443.[Abstract/Free Full Text]
  35. Weisberg, E., M. Sattler, D. S. Ewaniuk, R. Salgia. 1997. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit. Rev. Oncog. 8:343.[Medline]
  36. Turner, C. E., J. J. Glenney, K. Burridge. 1990. Paxillin: a new vinculin-binding protein present in focal adhesions. J. Cell Biol. 111:1059.[Abstract/Free Full Text]
  37. Salgia, R., S. Avraham, E. Pisick, J. L. Li, S. Raja, E. A. Greenfield, M. Sattler, H. Avraham, J. D. Griffin. 1996. The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J. Biol. Chem. 271:31222.[Abstract/Free Full Text]
  38. Hiregowdara, D., H. Avraham, Y. Fu, R. London, S. Avraham. 1997. Tyrosine phosphorylation of the related adhesion focal tyrosine kinase in megakaryocytes upon stem cell factor and phorbal myristate acetate stimulation and its association with paxillin. J. Biol. Chem. 272:10804.[Abstract/Free Full Text]
  39. Stanley, E. R.. 1985. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol. 116:564.[Medline]
  40. Lauffenburger, D. A., A. F. Horwitz. 1996. Cell migration: a physically integrated process. Cell 84:359.[Medline]
  41. Boocock, C. A., G. E. Jones, E. R. Stanley, J. W. Pollard. 1989. Colony stimulating factor-1 induces rapid behavioral responses in the mouse macrophage cell line BAC1.2F5. J. Cell Sci. 93:447.[Abstract/Free Full Text]
  42. Kharbanda, S., A. Saleem, Z. Yuan, Y. Emoto, K. V. Prasad, D. Kufe. 1995. Stimulation of human monocytes with macrophage colony-stimulating factor induces a Grb2-mediated association of the focal adhesion kinase pp125FAK and dynamin. Proc. Natl. Acad. Sci. USA 92:6132.[Abstract/Free Full Text]
  43. Dikic, I., G. Tokiwa, S. Lev, S. A. Courtneidge, J. Schlessinger. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383:547.[Medline]
  44. De Nichilo, N. O., K. M. Yamada. 1996. Integrin {alpha}vß5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin. J. Biol. Chem. 271:11016.[Abstract/Free Full Text]
  45. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brissette, E. J. Weringer, B. A. Pollok, P. A. Connelly. 1996. Discovery of a novel potent, and src-family selective tyrosine kinase inhibitor. J. Biol. Chem. 271:695.[Abstract/Free Full Text]
  46. Vlahos, C. J., W. F. Matter, R. F. Brown, A. E. Traynor-Kaplan, P. G. Heyworth, R. D. Ye, P. Marder, J. A. Schelm, K. Rothfus. 1995. Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. J. Immunol. 154:2413.[Abstract]
  47. Ostergaard, H. L., O. Lou, C. W. Arendt, N. Berg. 1998. Paxillin phosphorylation and association with Lck and Pyk2 in anti-CD3- or anti-CD45-stimulated T cells. J. Biol. Chem. 273:5692.[Abstract/Free Full Text]
  48. Gismondi, A., L. Bisogno, F. Mainiero, G. Palmieri, M. Piccoli, L. Frati, A. Santoni. 1997. Proline-rich tyrosine kinase-2 activation by ß1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J. Immunol. 159:4729.[Abstract]
  49. Lehto, V. P., T. Hovi, T. Vartio, R. A. Badley, I. Virtanen. 1981. Reorganization of cytoskeletal and contractile elements during transition of human monocytes into adherent macrophages. Lab. Invest. 47:391.[Medline]
  50. Marchisio, P. C., D. Cirillo, A. Teti, A. Zambonin-Zallone, G. Tarone. 1987. Rous sarcoma virus-transformed fibroblasts and cells of monocytic origin display a peculiar dot-like organization of cytoskeletal proteins involved in microfilament-membrane interactions. Exp. Cell Res. 169:202.[Medline]
  51. Berg, N. N., H. L. Ostergaard. 1997. T cell receptor engagement induces tyrosine phosphorylation of FAK and Pyk2 and their association with Lck. J. Immunol. 159:1753.[Abstract]
  52. Qian, D., S. Lev, N. S. van Oers, I. Dikic, J. Schlessinger, A. Weiss. 1997. Tyrosine phosphorylation of Pyk2 is selectively regulated by Fyn during TCR signaling. J. Exp. Med. 185:1253.[Abstract/Free Full Text]
  53. Schaller, M. D., T. Sasaki. 1997. Differential signaling by the focal adhesion kinase and cell adhesion kinase ß. J. Biol. Chem. 272:25319.[Abstract/Free Full Text]
  54. Tsuchida, M., S. J. Knechtle, M. M. Hamawy. 1999. CD28 ligation induces tyrosine phosphorylation of Pyk2 but not Fak in Jurkat T cells. J. Biol. Chem. 274:6735.[Abstract/Free Full Text]
  55. Richardson, A., R. K. Malik, J. D. Hildebrand, J. T. Parsons. 1997. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol. Cell Biol. 17:6909.
  56. Davis, C. B., I. Dikic, D. Unutmaz, C. M. Hill, J. Arthos, M. A. Siani, D. A. Thompson, J. Schlessinger, D. R. Littman. 1997. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186:1793.[Abstract/Free Full Text]
  57. Miyazaki, T., A. Takaoka, L. Nogueira, I. Dikic, H. Fujii, S. Tsujino, Y. Mitani, M. Maeda, J. Schlessinger, T. Taniguchi. 1998. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12:770.[Abstract/Free Full Text]
  58. Jeschke, M., G. J. R. Standke, M. Scaronuscarona. 1998. Fluoroaluminate induces activation and association of Src and Pyk2 tyrosine kinases in osteoblastic MC3TC-E1 cells. J. Biol. Chem. 273:11354.[Abstract/Free Full Text]
  59. Vanhaesebroeck, B., S. J. Leevers, G. Panayotou, M. D. Waterfield. 1997. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22:267.[Medline]
  60. Salim, K., M. J. Bottomley, E. Querfurth, M. J. Zvelebil, I. Gout, R. Scaife, R. L. Margolis, R. Gigg, C. I. Smith, P. C. Driscoll, M. D. Waterfield, G. Panayotou. 1996. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton’s tyrosine kinase. EMBO J. 15:6241.[Medline]
  61. Hatch, W. C., R. K. Ganju, D. Hiregowdara, S. Avraham, J. E. Groopman. 1998. The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocytes-macrophages. Blood 91:3967.[Abstract/Free Full Text]
  62. Rodriguez-Viciana, P., P. H. Warne, A. Khwaja, P. H. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457.[Medline]
  63. Nobes, C. D., A. Hall. 1995. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53.[Medline]
  64. Allen, W. E., G. E. Jones, J. W. Pollard, A. J. Ridley. 1997. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J. Cell Sci. 110:707.[Abstract]
  65. Turner, C. E., M. C. Brown, J. A. Perrotta, M. C. Riedy, S. N. Nikolopoulos, A. R. McDonald, S. Bagrodia, S. Thomas, P. S. Leventhal. 1999. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: a role in cytoskeletal remodeling. J. Cell Biol. 145:851.[Abstract/Free Full Text]
  66. Zheng, C., Z. Xing, Z. C. Bian, C. Guo, A. Akbay, L. Warner, J. L. Guan. 1998. Differential regulation of Pyk2 and focal adhesion kinase (FAK). J. Biol. Chem. 273:2384.[Abstract/Free Full Text]
  67. Matsuya, M., H. Sasaki, H. Aoto, T. Mitaka, K. Nagura, T. Ohba, M. Ishino, S. Takahashi, R. Suzuki, T. Sasaki. 1998. Cell adhesion kinase ß forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J. Biol. Chem. 273:1003.[Abstract/Free Full Text]
  68. Sieg, D. J., D. Ilic, K. C. Jones, C. H. Damsky, T. Hunter, D. Schlaepfer. 1998. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signalling events but Pyk2 does not fully function to enhance FAK-cell migration. EMBO J. 17:5933.[Medline]
  69. Fuortes, M., M. Melchior, H. Han, G. J. Lyon, C. Nathan. 1999. Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J. Clin. Invest. 104:327.[Medline]
  70. Lipsky, B. P., C. R. Beals, D. E. Staunton. 1998. Leupaxin is a novel LIM domain protein that forms a complex with Pyk-2. J. Biol. Chem. 273:11709.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
P. C. Patel and R. E. Harrison
Membrane Ruffles Capture C3bi-opsonized Particles in Activated Macrophages
Mol. Biol. Cell, November 1, 2008; 19(11): 4628 - 4639.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. D. Palmer, B. E. Mutch, S. Workman, J. P. McDaid, N. J. Horwood, and B. M. J. Foxwell
Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NF{kappa}B activity
Blood, February 15, 2008; 111(4): 1781 - 1788.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. F. Bradfield, C. A. Johnson-Leger, C. Zimmerli, and B. A. Imhof
LPS differentially regulates adhesion and transendothelial migration of human monocytes under static and flow conditions
Int. Immunol., February 1, 2008; 20(2): 247 - 257.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. Gil-Henn, O. Destaing, N. A. Sims, K. Aoki, N. Alles, L. Neff, A. Sanjay, A. Bruzzaniti, P. De Camilli, R. Baron, et al.
Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2 / mice
J. Cell Biol., September 7, 2007; 178(6): 1053 - 1064.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. McPhillips, W. J. Janssen, M. Ghosh, A. Byrne, S. Gardai, L. Remigio, D. L. Bratton, J. L. Kang, and P. Henson
TNF-{alpha} Inhibits Macrophage Clearance of Apoptotic Cells via Cytosolic Phospholipase A2 and Oxidant-Dependent Mechanisms
J. Immunol., June 15, 2007; 178(12): 8117 - 8126.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. M. Nikolic, J. Cholewa, C. Gass, M. C. Gong, and S. R. Post
Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1450 - C1458.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. B. Lasunskaia, M. N. N. Campos, M. R. M. de Andrade, R. A. DaMatta, T. L. Kipnis, M. Einicker-Lamas, and W. D. Da Silva
Mycobacteria directly induce cytoskeletal rearrangements for macrophage spreading and polarization through TLR2-dependent PI3K signaling
J. Leukoc. Biol., December 1, 2006; 80(6): 1480 - 1490.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lemarie, C. Morzadec, E. Bourdonnay, O. Fardel, and L. Vernhet
Human macrophages constitute targets for immunotoxic inorganic arsenic.
J. Immunol., September 1, 2006; 177(5): 3019 - 3027.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Kay, R. Z. Murray, J. K. Pagan, and J. L. Stow
Cytokine Secretion via Cholesterol-rich Lipid Raft-associated SNAREs at the Phagocytic Cup
J. Biol. Chem., April 28, 2006; 281(17): 11949 - 11954.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Cai, M. Li, J. Vrana, and M. D. Schaller
Glycogen synthase kinase 3- and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement.
Mol. Cell. Biol., April 1, 2006; 26(7): 2857 - 2868.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
D. Aki, R. Mashima, K. Saeki, Y. Minoda, M. Yamauchi, and A. Yoshimura
Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages
Genes Cells, April 1, 2005; 10(4): 357 - 368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Melendez, C. Turner, H. Avraham, S. F. Steinberg, E. Schaefer, and M. A. Sussman
Cardiomyocyte Apoptosis Triggered by RAFTK/pyk2 via Src Kinase Is Antagonized by Paxillin
J. Biol. Chem., December 17, 2004; 279(51): 53516 - 53523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Fessler, P. G. Arndt, S. C. Frasch, J. G. Lieber, C. A. Johnson, R. C. Murphy, J. A. Nick, D. L. Bratton, K. C. Malcolm, and G. S. Worthen
Lipid Rafts Regulate Lipopolysaccharide-induced Activation of Cdc42 and Inflammatory Functions of the Human Neutrophil
J. Biol. Chem., September 17, 2004; 279(38): 39989 - 39998.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Honstettre, E. Ghigo, A. Moynault, C. Capo, R. Toman, S. Akira, O. Takeuchi, H. Lepidi, D. Raoult, and J.-L. Mege
Lipopolysaccharide from Coxiella burnetii Is Involved in Bacterial Phagocytosis, Filamentous Actin Reorganization, and Inflammatory Responses through Toll-Like Receptor 4
J. Immunol., March 15, 2004; 172(6): 3695 - 3703.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. S. Zhou, D. S. Friend, A. M. Feldweg, M. Daheshia, L. Li, K. F. Austen, and H. R. Katz
Prevention of Lipopolysaccharide-induced Microangiopathy by gp49B1: Evidence for an Important Role for gp49B1 Expression on Neutrophils
J. Exp. Med., October 20, 2003; 198(8): 1243 - 1251.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. J. Horwood, T. Mahon, J. P. McDaid, J. Campbell, H. Mano, F. M. Brennan, D. Webster, and B. M.J. Foxwell
Bruton's Tyrosine Kinase Is Required For Lipopolysaccharide-induced Tumor Necrosis Factor {alpha} Production
J. Exp. Med., June 16, 2003; 197(12): 1603 - 1611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Pedron, R. Girard, and R. Chaby
TLR4-dependent Lipopolysaccharide-induced Shedding of Tumor Necrosis Factor Receptors in Mouse Bone Marrow Granulocytes
J. Biol. Chem., May 30, 2003; 278(23): 20555 - 20564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Worthylake and K. Burridge
RhoA and ROCK Promote Migration by Limiting Membrane Protrusions
J. Biol. Chem., April 4, 2003; 278(15): 13578 - 13584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L.-Y. Chen, B. L. Zuraw, M. Zhao, F.-T. Liu, S. Huang, and Z. K. Pan
Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L607 - L613.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. Ferlito, O. G. Romanenko, K. Guyton, S. Ashton, F. Squadrito, P. V. Halushka, and J. A. Cook
Implication of G i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production
Innate Immunity, December 1, 2002; 8(6): 427 - 435.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Dunty and M. D. Schaller
The N Termini of Focal Adhesion Kinase Family Members Regulate Substrate Phosphorylation, Localization, and Cell Morphology
J. Biol. Chem., November 15, 2002; 277(47): 45644 - 45654.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. R. Yan, W. Al-Hertani, D. Byers, and R. Bortolussi
Lipopolysaccharide-Binding Protein- and CD14-Dependent Activation of Mitogen-Activated Protein Kinase p38 by Lipopolysaccharide in Human Neutrophils Is Associated with Priming of Respiratory Burst
Infect. Immun., August 1, 2002; 70(8): 4068 - 4074.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Ameixa and J. S. Friedland
Interleukin-8 Secretion from Mycobacterium tuberculosis-Infected Monocytes Is Regulated by Protein Tyrosine Kinases but Not by ERK1/2 or p38 Mitogen-Activated Protein Kinases
Infect. Immun., August 1, 2002; 70(8): 4743 - 4746.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Paulhe, C. Racaud-Sultan, A. Ragab, C. Albiges-Rizo, H. Chap, N. Iberg, O. Morand, and B. Perret
Differential Regulation of Phosphoinositide Metabolism by alpha Vbeta 3 and alpha Vbeta 5 Integrins upon Smooth Muscle Cell Migration
J. Biol. Chem., November 2, 2001; 276(45): 41832 - 41840.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
S. H. Diks, S. J.H. van Deventer, and M. P. Peppelenbosch
Invited review: Lipopolysaccharide recognition, internalisation, signalling and other cellular effects
Innate Immunity, October 1, 2001; 7(5): 335 - 348.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
S. Jeyaseelan, M. S. Kannan, R. E. Briggs, P. Thumbikat, and S. K. Maheswaran
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects
Infect. Immun., October 1, 2001; 69(10): 6131 - 6139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Latour, H. Tanaka, C. Demeure, V. Mateo, M. Rubio, E. J. Brown, C. Maliszewski, F. P. Lindberg, A. Oldenborg, A. Ullrich, et al.
Bidirectional Negative Regulation of Human T and Dendritic Cells by CD47 and Its Cognate Receptor Signal-Regulator Protein-{alpha}: Down-Regulation of IL-12 Responsiveness and Inhibition of Dendritic Cell Activation
J. Immunol., September 1, 2001; 167(5): 2547 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
G. M. Scholz, S. D. Hartson, K. Cartledge, L. Volk, R. L. Matts, and A. R. Dunn
The Molecular Chaperone Hsp90 Is Required for Signal Transduction by Wild-Type Hck and Maintenance of Its Constitutively Active Counterpart
Cell Growth Differ., August 1, 2001; 12(8): 409 - 417.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-S. Bae, H. Bae, Y. Kim, T. G. Lee, P.-G. Suh, and S. H. Ryu
Identification of novel chemoattractant peptides for human leukocytes
Blood, May 1, 2001; 97(9): 2854 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Meconi, C. Capo, M. Remacle-Bonnet, G. Pommier, D. Raoult, and J.-L. Mege
Activation of Protein Tyrosine Kinases by Coxiella burnetii: Role in Actin Cytoskeleton Reorganization and Bacterial Phagocytosis
Infect. Immun., April 1, 2001; 69(4): 2520 - 2526.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. J. Pixley, P. S. W. Lee, J. S. Condeelis, and E. R. Stanley
Protein Tyrosine Phosphatase {phi} Regulates Paxillin Tyrosine Phosphorylation and Mediates Colony-Stimulating Factor 1-Induced Morphological Changes in Macrophages
Mol. Cell. Biol., March 1, 2001; 21(5): 1795 - 1809.
[Abstract] [Full Text]


Home page
HypertensionHome page
U. Kintscher, S. Wakino, S. Kim, E. Fleck, W. A. Hsueh, and R. E. Law
Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes
Hypertension, February 1, 2001; 37(2): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Watson, T. W. Harding, V. Golubovskaya, J. S. Morris, D. Hunter, X. Li, J. S. Haskill, and H. S. Earp
Inhibition of the Calcium-dependent Tyrosine Kinase (CADTK) Blocks Monocyte Spreading and Motility
J. Biol. Chem., January 26, 2001; 276(5): 3536 - 3542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Wang, M. A. Jobst, B. Bell, C.-R. Zhao, L.-H. Shang, and D. O. Jacobs
Cr supplementation decreases tyrosine phosphorylation of the CreaT in skeletal muscle during sepsis
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1046 - E1054.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, L. M.
Right arrow Articles by Ridley, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, L. M.
Right arrow Articles by Ridley, A. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS